Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
Year: 2019
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Cognitive decline is a frequent complication of Parkinson's disease (PD) and the identification of predictive biomarkers for it would help in its management. OBJECTIVE: Our aim was to analyse whether senescence markers (telomere length, p16 and p21) or their change over time could help to better predict cognitive and motor progression of newly diagnosed PD patients. We also compared these senescence markers to previously analysed markers of inflammation for the same purpose. METHODS: This study examined the association of blood-derived markers of cell senescence and inflammation with motor and cognitive function over time in an incident PD cohort (the ICICLE-PD study). Participants (154 newly diagnosed PD patients and 99 controls) underwent physical and cognitive assessments over 36 months of follow up. Mean leukocyte telomere length and the expression of senescence markers p21 and p16 were measured at two time points (baseline and 18 months). Additionally, we selected five inflammatory markers from existing baseline data. RESULTS: We found that PD patients had shorter telomeres at baseline and 18 months compared to age-matched healthy controls which also correlated to dementia at 36 months. Baseline p16 levels were associated with faster rates of motor and cognitive decline over 36 months in PD cases, while a simple inflammatory summary score at baseline best predicted cognitive score over this same time period in PD patients. CONCLUSION: Our study suggests that both inflammatory and senescence markers (p16) are valuable predictors of clinical progression in PD patients.
Source: Journal of Parkinson s Disease
DOI: 10.3233/jpd-191724
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: Wellcome Trust, UK Research and Innovation, National Institute for Health and Care Research, Department of Health and Social Care, Parkinson's UK, Research Councils UK, Academy of Medical Sciences, Newcastle University, Rosetrees Trust, Cambridge University Hospitals, Newcastle upon Tyne Hospitals NHS Foundation Trust, Medical Research Council, NIHR Newcastle Biomedical Research Centre, NIHR Cambridge Biomedical Research Centre
Awards: G2328035839, G2607745411, G3046909538, NIHR Senior Investigator Award, G3570280960, G3967042023, The NET-PDD study: defining the roles of NEuroinflammation and Tau aggregation in Parkinson's Disease Dementia, The Newcastle 85+ Study: maintaining the health of the very old, G6552962396, G6594593631, G6989655635, G7079897206, Cambridge Stem Cell Institute, G8585681489
OpenAlex ID: W2980634970
